TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: macroscopic hematuria
Endpoint domain: Adverse events/effects
Primary endpoint: rectal blood loss
Endpoint domain: Adverse events/effects
Primary endpoint: fever and LUTS
Endpoint domain: Adverse events/effects
Primary endpoint: Preoperative hypertension (HTN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative hypertension (HTN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of head, face and neck injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rate of injuries causing players to miss a game
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average bubble count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuous illness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment with antidepressant or psychotherapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Food security
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Health care for children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived physical health benefits
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HI-Erythroid response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in RBC transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean resting diastolic pressure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean resting systolic pressure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean peak diastolic pressure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Histamine level measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: PTGI
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Post-treatment self-efficacy rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Airway responsiveness to NKA (PC20NKA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Airway responsiveness to histamine (PC20)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pathologic fractures
Endpoint domain: Mortality/survival
Primary endpoint: Analgesic effect
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: intraoperative adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: mesorectal fascial plane resections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: MYMOP score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: facial vertical dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anchorage gain and intrusion of molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: facial convexity angle, nasolabial angle, and lower lip protrusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of HIV culture negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Development of AIDS-defining opportunistic infections
Endpoint domain: Adverse events/effects
Primary endpoint: Time to deterioration of sore mouth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to deterioration of alopecia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of euploid blastocysts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance score to metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood pressure checked
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cholesterol checked
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived receipt of excellent/good care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detectable levels of VEGF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Recoverin levels in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Fewer negative emotional manifestations
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Higher level of satisfaction with procedures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Endothelial resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPP of successful intercourse attempts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPP of Erection Hardness Score 4 erections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction with erection hardness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: suppression of titrated skin prick tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: increase in dog-specific IgG(4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: suppression of secreted TNF-alpha
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: consistent bedtime maintenance
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: consistent rising time maintenance
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: daily walking
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: postoperative wound blood drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: number of patients who got blood transfusion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Completion rate of questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Bradykinin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Ang II/Ang I ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: BK-(1-7)/BK-(1-9) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: pooled eradication rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ottawa bowel preparation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inadequate bowel preparations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: VAS scores for pain on movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in physical and behavioural symptoms of PMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of cranial nerve dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Problem-solving performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Executive function performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Response to treatment (gain of at least 10 dB or 15% improvement in SDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of OlPN
Endpoint domain: Adverse events/effects
Primary endpoint: Vaccine response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: plasma median levels of tPA mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: tPA/PAI‐1 complex levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: PImax measurements variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive somatostatin receptor scintigraphy predicting hormonal response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative somatostatin receptor scintigraphy predicting no visual improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscular strength (MVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forearm girth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak forearm vascular conductance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Breast cancer screening adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: IL-4 and TNF-alpha levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Symptoms score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elevation of any troponin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major adverse coronary events
Endpoint domain: Adverse events/effects
Primary endpoint: Salivary α‐amylase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sense of calmness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: sodium levels (sNa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: urinary sodium levels (uNa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma free fatty acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: cardiac PCr/ATP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Infant crying knowledge score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shaking knowledge score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Information sharing behaviors
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: groin pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary anastomosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Performance of positive OSCE items
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarker sensitivity and specificity for concussion assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: incidence of anterior open bites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NKG2D expression level of NK cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Killing rate of NK cells for K562 cell
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of NKG2D(+)NK cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction rate of endothelium corneal cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sputum ECP levels reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive distal resection margin (DRM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Positive circumferential resection margin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Median number of resected lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: grade 4 haematological toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: grade ≥ 2 neuropathy
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of potentially significant abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnosis of primary extrathoracic cancers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Completion of counseling
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Testing results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSNRT (Conduction time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CSACT (Conduction time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pelvic excursion in frontal plane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interference of symptoms with life
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Unsuccessful outcome
Endpoint domain: Adverse events/effects
Primary endpoint: Time from door-to-randomization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median reduction in nausea score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for rescue anti-emetic
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Efficacy of Aerodiol compared to oral estradiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of mastalgia
Endpoint domain: Adverse events/effects
Primary endpoint: cosmetic deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-year cosmesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: facility discharge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Muscle elbow flexion and extension isometric and isokinetic torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: combined index of symptom severity (CODI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful closure of perforation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Response heterogeneity to G. biloba treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Episodes of bacteremia with enterobacteriacae
Endpoint domain: Adverse events/effects
Primary endpoint: Medication dosing errors
Endpoint domain: Adverse events/effects
Primary endpoint: Time to medication administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of exposed bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discontinuation of analgesics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete recovery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: NH placement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Lag phase of LDL oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: brain tissue metabolic status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: serum uric acid concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Retears on MRI
Endpoint domain: Adverse events/effects
Primary endpoint: [(3)H]‐DHPG to [(3)H]‐NE ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central coherence
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: HPV-16/18 viral clearance rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Urinary cGMP/creatinine (U cGMP/Cr) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary cAMP/creatinine (U cAMP/Cr) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of the latent phase of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temperature of inspired gas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Absolute humidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction in BAI score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of panic attacks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Avoidant behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Carotenoid levels in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activities of PON-1 and LCAT in HDL3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in SCORAD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease in staphylococci load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Modification of dermatology life quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: drop of pre‐operative to post‐operative haemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: maternal death
Endpoint domain: Mortality/survival
Primary endpoint: Reflux recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of pediatric medication misuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication-related communication during visits
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Satisfaction with dyspepsia-related health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Global scores for Glasgow Dyspepsia Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global scores for Dyspepsia-Related Health Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neurocognitive measures of memory and executive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cervical opening time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: child behavior problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative peak creatine kinase-MB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Required inotropes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Transcardiac neutrophil count during reperfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in perception and attention to moving stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Non-inferiority of CMR perfusion imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean percentage of heartburn-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of EUS-FNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive predictive value of EUS-FNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heparin contamination rate in blood samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Patient participation in end-of-life treatment conversations
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Documentation of patient's preferences, hopes, and worries
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concordance between provided treatment and patient preferences
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Extravascular lung water index (ELWI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Geometric mean titer (GMT) of the neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of Traveler's Diarrhea (TD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative insulin requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean percent improvement in AEP scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: QOLIE-89 score improvement (>15 points)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of acute coronary findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of patients classified as dying of myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: levodopa exposure (area under the curve)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of dementia-specific case conferences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes